Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced Karen S. Lynch has been elected to its board of directors, effective February 19, 2025. The appointment ...

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors authorized a quarterly cash dividend of $0.43 per common share, payable on ...

Biopharmaceutical CMO Market Rapid outsourcing trends and robust investments in advanced manufacturing drive the biopharmaceutical CMO mark ...

Abhijit Naravane, a partner at PA Consulting, outlines strategies to help biopharma operations leaders successfully navigate ...

Thermo Fisher Scientific Inc. (TMO), headquartered in Waltham, Massachusetts, offers life sciences solutions, analytical ...

The 35th Annual IFTSA and Mars Product Development Competition is a chance for students to take the skills and knowledge learned in school and apply them to a real-world situation. Each participating ...

Relmada continues to evaluate additional product and strategic opportunities. The Company anticipates hosting an investor update on Sepranolone’s next development steps later in 2025.

drowning on and on about how much the team put into the product. The result is that the development team dives in, optimistically, but beneath this optimism lies a quiet risk: Are they building ...

This is the 12th independent registry from CorEvitas, part of the PPD™ clinical research business ... of AA in adolescents and the growth and development over time of adolescent AA patients ...

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced a 10-year virtual power purchasing agreement (VPPA) with international renewable energy developer X-ELIO ...

Medidata, a Dassault Systèmes brand, reaffirms its vision and commitment to advancing the life sciences industry and ...